EMPLOYEE LOGIN
Corporate and Investor Info
Who We Are
Quality
Board of Directors
Our Senior Team
News
Upcoming Events
Financial Reports
Stock Info
Presentations
Analyst Coverage
Corporate Governance
For IVD Manufacturers
View All Antigens (Raw Materials)
Childhood Disease Antigens
Dengue Antigens
STI Antigens
Gastrointestinal
ToRCH Antigens
Respiratory Antigens
Controls (QAPs™)
View All QAPs™
SARS Complete Panel
Respiratory Viral Panel
STI Panel
HPV Panel
Gastrointestinal Panel
ONBOARDx™ Kits
Proficiency Testing
QAPs Distributor Network
Technical Resources
0 Items
Corporate and Investor Info
Who We Are
Quality
Board of Directors
Our Senior Team
News
Upcoming Events
Financial Reports
Stock Info
Presentations
Analyst Coverage
Corporate Governance
For IVD Manufacturers
View All Antigens (Raw Materials)
Childhood Disease Antigens
Dengue Antigens
STI Antigens
Gastrointestinal
ToRCH Antigens
Respiratory Antigens
Controls (QAPs™)
View All QAPs™
SARS Complete Panel
Respiratory Viral Panel
STI Panel
HPV Panel
Gastrointestinal Panel
ONBOARDx™ Kits
Proficiency Testing
QAPs Distributor Network
Technical Resources
Select Page
customer.service@microbix.com
+1-905-361-8910 +1-800-794-6694 (Toll Free)
Search for:
Search Button
Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6/E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods
By Microbix Admin | October 24, 2022
Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Controls
By Microbix Admin | October 24, 2022
Emerging requirements for infectious disease IVD quality control material
By Microbix Admin | October 18, 2022